The Worldwide Market for In Vitro Diagnostic (IVD) Tests.pdf
《The Worldwide Market for In Vitro Diagnostic (IVD) Tests.pdf》由会员分享,可在线阅读,更多相关《The Worldwide Market for In Vitro Diagnostic (IVD) Tests.pdf(945页珍藏版)》请在三一文库上搜索。
1、Worldwide Market for IVD Tests 6th Ed. Rures adquireret umbraculi, etiam tremulus matrimonii libere senesceret appJune 2008 (preface Dec. 2008) Kalorama Information A division of MarketR 38 East 29th Street Sixth Floor New York, New York 10016 212.807 .2660 t 800.298.5603 t 212.807 .2676 f Copyrigh
2、t 2008 Kalorama Information Reproduction without prior written permission, in any media now in existence or hereafter developed, in whole or in any part, is strictly prohibited THE WORLDWIDE MARKET FOR IN VITRO DIAGNOSTIC TESTS 6TH EDITION A KALORAMA INFORMATION MARKET INTELLIGENCE REPORT The Worldw
3、ide Market for In Vitro Diagnostic Tests, 6th Ed. has been prepared by Kalorama Information. We serve business and industrial clients worldwide with a complete line of information services and research publications. Kalorama Information Market Intelligence Reports are specifically designed to aid th
4、e action- oriented executive by providing a thorough presentation of essential data and concise analysis. Author: Shara Rosen Publication Date: June 2008 38 East 29th Street New York, New York 10016 http:/www.KaloramaI E- MAIL: KLI1430266 Copyright 2008 Kalorama Information Reproduction without pri
5、or written permission, in any media now in existence or hereafter developed, in whole or in any part, is strictly prohibited Special Addendum: IVD andthe Economy in 2009 This report was completed in June 2008 before the economic meltdown of 2008/2009 was fully apparent. The report estimates that the
6、 world market for IVD products is $42 billion in 2007 and is expected to grow 6% annually to $56 billion by 2012. While we have not conducted a complete update of this product, our analyst Shara Rosen has reviewed the market and the assumptions in this report. Based on that review, .Kalorama Informa
7、tion anticipates that this estimate holds true in spite of the current financial situation. There are many reasons for this finding. IVD Has Already Seen Cuts IVD has a twenty year history of scaling down due to economic woes. In vitro diagnostics were the first products targeted for cutbacks in the
8、 major markets the U.S., Europe and Japan. Since the late 1980s healthcare payers have systematically frozen reimbursement rates for the existing group of tests and have imposed strict utilization guidelines for the adoption of new tests. Kaloramas IVD Forecasts Have Been Conservative The IVD indust
9、ry did not experience the explosive growth seen in some medical devices. In addition, Kalorama analysts make conservative market predictions, erring if at all on the lower side of forecasts derived from secondary research and primary research interviews. Group Purchasing by Hospitals In the U.S. the
10、 American Hospital Association estimates that at least 70% of hospitals are members of a hospital system or participate in a group purchasing organization. Thus the majority of labs located in the largest single market for IVD products, the U.S., acquire their instruments, reagents and supplied for
11、routine tests at rock bottom and discounted prices. Copyright 2008 Kalorama Information Reproduction without prior written permission, in any media now in existence or hereafter developed, in whole or in any part, is strictly prohibited Federal Focus on Healthcare New healthcare initiatives proposed
12、 by the new U.S. administration under the guidance of President Barack Obama will require testing and thus further bolster the use of IVDs. Demand Increasing Demand for healthcare and thus diagnostic tests in all the major markets is driven by aging populations and increased incidence of conditions
13、such as: cancer, diabetes, cardiovascular disease, arthritis and obesity. There is an emerging menu of specialized tests for these diseases, but routine tests are used as the first line of diagnosis. Routine Testing Bulk of Market Numbers Therefore market growth for chemistries, immunoassays, hemato
14、logy, coagulation, microbiology and histology/cytology is related to an increase in the volume of tests performed rather than higher pricing. More demand for healthcare translates into more routine tests performed. The market for these routine test segments account for some 49% of the market for IVD
15、 products. Emerging Markets Emerging markets, primarily China and India, will still experience market growth of 10- 14%. This is fuelled by privatization and health insurance initiatives by governments and employers. But even at 15% market growth, IVD expenditures in China, L. America and India add
16、only $480 million dollars to the world market for IVDs. For these reasons, we believe the expansion of the market for IVDs will continue at its traditional rate of some 6% per year. Copyright 2008 Kalorama Information Reproduction without prior written permission, in any media now in existence or he
17、reafter developed, in whole or in any part, is strictly prohibited THE WORLDWIDE MARKET IN VITRO DIAGNOSTIC TESTS 6TH EDITION A KALORAMA INFORMATION MARKET INTELLIGENCE REPORT The Worldwide Market for In Vitro Diagnostic Tests, 6th Ed. has been prepared by Kalorama Information. We serve business and
18、 industrial clients worldwide with a complete line of information services and research publications. Kalorama Information Market Intelligence Reports are specifically designed to aid the action- oriented executive by providing a thorough presentation of essential data and concise analysis. Author:
19、Shara Rosen Publication Date: June 2008 38 East 29th Street New York, New York 10016 http:/www.KaloramaI E- MAIL: KLI1430266 Copyright 2008 Kalorama Information Reproduction without prior written permission, in any media now in existence or hereafter developed, in whole or in any part, is strictly
20、prohibited TABLE OF CONTENTS CHAPTER ONE: EXECUTIVE SUMMARY.1 Overview 1 Size and Growth of the Market. 3 Important Changes in the IVD Market. 7 IVD Growth in Developed Countries 7 Privatization of Healthcare. 7 Newly Aggressive Foundations and Initiatives 7 Positive and Negative Market Trends. 7 Hu
21、man Genome Project Applications 7 Remote Patient Monitoring 8 Demand for Data 8 The Informed Medical Consumer. 9 Price Point of New Products. 9 Focus On Home Care Raises Questions. 9 Top Suppliers and Niche Players 10 Scope and Methodology . 13 Exchange Rates 13 Scope 14 Methodology 14 CHAPTER TWO:
22、INTRODUCTION17 New Report Design. 18 Lab Medicine Disciplines and Applications . 19 Core Lab. 19 Market Analysis of IVD Market Segments 23 Age of the Giants and Smaller colossuses. 26 Licenses and Distribution Agreements . 30 Top Suppliers and Niche Players 34 Point of View. 37 CHAPTER THREE: OVERVI
23、EW OF GLOBAL IN VITRO DIAGNOSTIC MARKETS39 The Boomers and Aging Worldwide. 40 Healthcare Spending Worldwide 42 World Segments of the IVD Market and IVD Market Evolution. 47 The United States . 48 JapanJust Barely Holding Its Own . 55 Europe 56 China 60 ii The Worldwide Market for In Vitro Diagnosti
24、c Tests, 6th Ed Copyright 2008 Kalorama Information Reproduction without prior written permission, in any media now in existence or hereafter developed, in whole or in any part, is strictly prohibited India63 Africa65 CHAPTER FOUR: TRENDS IN HEALTHCARE DELIVERY AND IN VITRO DIAGNOSTICS.67 The Wellne
- 配套讲稿:
如PPT文件的首页显示word图标,表示该PPT已包含配套word讲稿。双击word图标可打开word文档。
- 特殊限制:
部分文档作品中含有的国旗、国徽等图片,仅作为作品整体效果示例展示,禁止商用。设计者仅对作品中独创性部分享有著作权。
- 关 键 词:
- The Worldwide Market for In Vitro Diagnostic IVD Tests IVD
链接地址:https://www.31doc.com/p-3800952.html